Core Viewpoint - The company, Guomin Technology Co., Ltd., plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international presence and competitiveness [1][2]. Group 1: Meeting Details - The sixth session of the company's supervisory board was held on May 29, 2025, with all three supervisors present [1]. - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1]. Group 2: H-Share Issuance Proposal - The supervisory board approved the proposal for issuing H-shares and applying for listing on the Hong Kong Stock Exchange to accelerate the company's overseas strategic layout [1][2]. - The proposal received unanimous support with 3 votes in favor, 0 against, and 0 abstentions [2]. Group 3: Issuance Details - The H-shares will have a nominal value of RMB 1.00 and will be issued in foreign currency [2]. - The company plans to issue no more than 20% of its total share capital in H-shares post-listing, subject to shareholder approval [4]. Group 4: Fund Utilization Plan - The funds raised from the H-share issuance will be used for R&D, repaying bank loans, and supplementing working capital [8][9]. - If the raised funds are insufficient for project needs, the company will seek alternative funding solutions [8]. Group 5: Regulatory Compliance - The issuance will comply with relevant laws and regulations, including the Listing Rules of the Hong Kong Stock Exchange [2][3]. - The company will determine the specific issuance timing based on market conditions and regulatory approvals [3]. Group 6: Insurance and Audit - The company plans to purchase liability insurance for directors and senior management, subject to shareholder approval [10]. - Deloitte will be appointed as the auditing firm for the H-share issuance [11].

股票代码：002768 股票简称：国恩股份 公告编号：2025-024 青岛国恩科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 青岛国恩科技股份有限公司（以下简称"公司"或"国恩股份"）第五届监 事会第十一次会议于 2025 年 5 月 26 日 15:30 在青岛市城阳区棘洪滩街道青大工 业园 2 号路公司四楼会议室召开。本次会议由监事会主席王龙先生提议召开并主 持，会议通知于 2025 年 5 月 23 日以专人送达、电子邮件、电话等形式发出。本 次会议应到监事 3 名，实到监事 3 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》（以下简称"《公司法》"）等法律法规和《青岛国 恩科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，合法有 效。 二、监事会会议审议情况 议案》 公司发行境外上市外资股（H 股）股票并申请于香港联合交易所有限公司 （以下简称"香港联交所"）主板挂牌上市（以下简称"本次发行"、"本次发 行上市"或"本次发行并上市"）有利于深入推进公司全球化战略布局，打造国 际化 ...

证券代码：603501 证券简称：韦尔股份 公告编号：2025-052 转债代码：113616 转债简称：韦尔转债 上海韦尔半导体股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 上海韦尔半导体股份有限公司（以下简称"公司"）第六届监事会第三十 五次会议于2025年5月23日以现场结合通讯方式召开，会议通知已于2025年5月 应到监事3人，实到监事3人。本次会议的召集和召开符合《公司法》等有关法 律、行政法规、部门规章、规范性文件和《公司章程》的有关规定，会议形成 的决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于公司发行 H 股股票并在香港联合交易所有限公司主 板上市的议案》 为加快公司的国际化战略及海外业务发展，增强公司的境外融资能力，进 一步提高公司的综合竞争力，根据公司总体发展战略及运营需要，公司拟发行 境外上市股份（H 股）并在香港联合交易所有限公司（以下简称"香港联交 所"）主板上市（以下简称"本次发行 H 股并上市"或"本次发行"）。 根据《中华人民共和国公司法》 ...

Core Viewpoint - Longqi Technology plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its capital strength, competitiveness, and international brand image, while advancing its globalization strategy [1] Group 1: H-Share Issuance - Longqi Technology's board and supervisory board approved the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1] - The issuance aims to meet the needs of the company's international business development and is subject to approval from relevant regulatory bodies [1] - The company is currently discussing the issuance with intermediary institutions, and specific details are yet to be determined [1] Group 2: Previous IPO Details - Longqi Technology was listed on the Shanghai Stock Exchange on March 1, 2024, with an issuance of 60 million shares, accounting for 12.90% of the total share capital post-issuance [2] - The issuance price was set at 26.00 yuan per share, raising a total of 156 million yuan, with a net amount of approximately 144.07 million yuan after expenses [2] - The funds raised are intended for various projects, including smart hardware manufacturing and operational capital [2] Group 3: Issuance Costs - The total issuance costs (excluding VAT) amounted to approximately 11.93 million yuan, with underwriting fees constituting about 8.38 million yuan [3]

兆易创新公告，为深化全球化战略布局，加快海外业务发展，提升公司国际化品牌形象，进一步提升公 司核心竞争力，公司拟发行境外上市外资股（以下简称H股）股票（以下简称本次发行）并在香港联合 交易所有限公司（以下简称香港联交所）主板挂牌上市（以下简称本次发行并上市）。公司将充分考虑 现有股东的利益和境内外资本市场的情况，在股东会决议有效期内（即经公司股东会审议通过之日起24 个月或同意延长的其他期限）选择适当的时机和发行窗口完成本次发行并上市。 ...

Financial Criteria Requirements - Hong Kong's stock market requires companies to have three consecutive years of profitability, with a cumulative profit of no less than 50 million HKD, and specific market capitalization and revenue thresholds [3] - The US stock market, particularly NASDAQ, allows companies to list with a three-year cumulative pre-tax profit of at least 11 million USD or high market capitalization and cash flow, providing more flexibility for high-growth tech companies [4] Listing Cycle - The typical IPO process in Hong Kong takes about 10-12 months, while in the US, it usually takes 6-9 months, with the possibility of shortening to 4-6 months through SPACs [5] Listing and Maintenance Costs - Listing costs in Hong Kong generally range from 2% to 5%, while underwriting commissions in the US are typically between 7% and 8% [6] - Annual maintenance costs in Hong Kong are lower, but companies must pay stamp duty, whereas US companies face higher annual audit and compliance fees [7] Regulatory and Compliance Requirements - Hong Kong's market is regulated by the SFC and HKEX, allowing VIE structures and offering more flexibility in information disclosure [8] - The US market is under strict SEC regulations, requiring adherence to the Sarbanes-Oxley Act and PCAOB audit standards, resulting in higher compliance costs [10][11] Market Liquidity and Valuation - The price-to-earnings ratio in Hong Kong is lower (approximately 10-20 times), with liquidity concentrated in blue-chip stocks, while the US market has a higher P/E ratio (NASDAQ around 20-30 times) and the strongest liquidity globally [12][13]

Core Viewpoint - Hunan Junxin Environmental Protection Co., Ltd. plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international competitiveness and brand image, as well as to accelerate its internationalization strategy and overseas business layout [2]. Group 1: Company Overview - Junxin Environmental Protection was established in 2011 and is a leading enterprise in the environmental protection sector in Hunan, focusing on solid waste treatment and green energy [4]. - The company has a total share capital of 564 million shares, with a market capitalization of approximately 11.52 billion yuan as of May 15 [4]. - The company operates projects primarily in Hunan and Kyrgyzstan, covering various waste treatment services [4]. Group 2: Financial Performance - In 2024, the company achieved a revenue of 2.431 billion yuan, representing a year-on-year growth of 30.86% [5]. - The net profit attributable to shareholders was 536 million yuan, an increase of 4.36% compared to the previous year [5]. Group 3: Shareholder Structure - The controlling shareholder and actual controller is Dai Daoguo, who directly holds 4.19% of the shares [7]. - Several family members of Dai Daoguo also hold shares in the company, making them acting in concert [7]. Group 4: Executive Compensation - In 2024, the total pre-tax remuneration for directors, supervisors, and senior management was 19.94 million yuan, with Dai Daoguo receiving 8.80 million yuan [9].

七部门：支持外商投资境内科技型企业，提高外资在华开展股权投资、创业投资便利性。用好合格境外 有限合伙人（QFLP）试点、跨境融资便利化试点政策，拓宽科技型企业跨境融资渠道。支持科技型企 业依法依规境外上市。 ...

证券代码：002130 证券简称：沃尔核材 公告编号：2025-033 深圳市沃尔核材股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳市沃尔核材股份有限公司（以下简称"公司"）第七届董事会第二十七 次会议通知于2025年5月8日（星期四）以电话及邮件方式送达给公司全体董事。 会议于2025年5月12日（星期一）以现场结合通讯会议方式在公司办公楼会议室 召开，会议应到董事8人，实到董事8人，公司监事、高管列席了本次会议。本次 董事会会议的召开符合国家有关法律、法规和《公司章程》的规定。会议由副董 事长、总经理易华蓉女士主持，审议通过了以下决议： 一、以8票同意、0票反对、0票弃权，审议通过了《关于同意控股子公司向 银行申请项目贷款额度并为其提供担保的议案》。 修订后的《公司章程》 《深圳市沃尔核材股份有限公司股东会议事规则》 《深 圳市沃尔核材股份有限公司董事会议事规则》详见 2025 年 5 月 13 日的巨潮资讯 网（www.cninfo.com.cn）。 本议案尚需提交股东大会审议。 三、逐项审议通过了《关于修订公司部分内部治理制度的议案》。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600276 证券简称：恒瑞医药 公告编号：临2025-072 江苏恒瑞医药股份有限公司 关于刊发境外上市外资股（H股）发行聆讯后资料集的公告 鉴于聆讯后资料集的刊发目的仅为提供信息予香港公众人士和合资格的投资者，公司将不会在境内证券 交易所的网站和符合监管机构规定条件的媒体上刊登该聆讯后资料集，但为使A股投资者及时了解该聆 讯后资料集披露的本次发行上市及公司的其他相关信息，现提供该聆讯后资料集在香港联交所网站的查 询链接： 中文： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 江苏恒瑞医药股份有限公司（以下简称"公司"）正在进行发行境外上市外资股（H股）股票并在香港联 合交易所有限公司（以下简称"香港联交所"）主板挂牌上市（以下简称"本次发行上市"）的相关工作。 2025年1月6日，公司向香港联交所递交了本次发行上市的申请，并于同日在香港联交所网站刊登了申请 资料。 2025年4月28日，中国证券监督管理委员会就公司本次发行上市出具《关于江苏恒瑞医药股份有限公司 ...